Form 4: AbbVie Director Roxanne S. Austin Reports Acquisition and Disposal of Shares
SEC Form 4 Filing
Director Roxanne S. Austin reports acquisition of restricted stock units and disposal of common stock.
Summary
- On May 3, 2024, Roxanne S. Austin, a director of AbbVie Inc., reported transactions involving AbbVie's common stock.
- Austin acquired 1,322 restricted stock units under the AbbVie Amended and Restated 2013 Incentive Stock Program.
- These restricted stock units will be paid in shares of AbbVie common stock upon separation from service, death, or a change in control.
- Austin also disposed of 37,255 shares of common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Future Outlook
The restricted stock units will be paid out in AbbVie common stock upon the director's separation from service, death, or a change in control, as defined in the AbbVie Amended and Restated 2013 Incentive Stock Program.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock. It's a standard practice for directors and officers of publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| July 10, 2023 | Date of Power of Attorney granted by Roxanne S. Austin. |
| May 03, 2024 | Date of transaction involving acquisition of restricted stock units and disposal of common stock. |
| May 07, 2024 | Date of signature by Attorney-in-Fact for Roxanne S. Austin. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.